Digital biomarkers are objective, quantifiable, physiological and behavioral data that are collected and measured by means of digital devices. Their use and evaluation is growing rapidly. Experts estimate that by 2025 seventy percent of all clinical trials will include digital biomarkers to explain and predict health outcomes. It is also expected that digital Biomarkers, capturing clinically meaningful and objective data by continuously monitoring patients and healthy individuals, will open a complete new field to a better understanding of the progression and the management of diseases. It is therefore not surprising that digital biomarkers are getting increasing attention from the pharma industry, academia and forward thinking health care professionals.
Our next DayOne Expert Event will be a deep dive into current applications of digital biomarkers and debate how digital devices such as portables, wearables, implantations or digestibles will shape the future of health.
When: October 22, starting from 6 pm
Where: University Hospital Basel, Zentrum für Lehre und Forschung, Hebelstrasse 20
Program
18:00
Doors open
18:30
Welcome
18:40
Introduction
by Jörg Goldhahn, ETH
19:00
Short presentations and Panel Discussion with
Emilio Merlo-Pich, Takeda; Clay Ieuan, Novartis; Jens Eckstein, University Hospital Basel; Jörg Goldhahn, ETHZ
19:45
Apero & Networking
Participation to the event is free of charge; however please register below via the registration link
